Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Other disposition Director disposed of 414,816 shares (other)
  4. 4 Open-market sale Director sold 3,035 shares at $86.87 ($263,636)
  5. 4 Open-market sale Director sold 8,965 shares at $86.98 ($779,777)
  6. 4 Open-market sale Director sold 1,155 shares at $84.89 ($98,045)
  7. 4 Open-market sale Director sold 22,845 shares at an average $85.36 ($1,949,996)
  8. 4 Open-market sale Director sold 60,000 shares at an average $92.51 ($5,550,644)
  9. 4 Open-market sale Chief Financial Officer sold 12,000 shares at an average $92.26 ($1,107,068)
  10. 4 Open-market sale President sold 25,000 shares at an average $92.62 ($2,315,578)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
  12. 4 Open-market sale President sold 25,000 shares at $100.00 ($2,500,000)
  13. 4 Other acquisition Director acquired 71 shares (other)
  14. 4 Open-market sale Chief Financial Officer sold 12,000 shares at an average $86.74 ($1,040,919)
  15. 4 Open-market sale President sold 25,000 shares at $90.00 ($2,250,000)
  16. 4 Open-market sale Director sold 20,000 shares at an average $82.39 ($1,647,730)
  17. 4 Open-market sale President sold 50,000 shares at $80.00 ($4,000,000)
  18. 4 Open-market sale CBO & COO sold 70,000 shares at an average $75.88 ($5,311,564)
  19. 4 Open-market sale President sold 50,000 shares at $75.00 ($3,750,000)
  20. 4 Open-market sale Director sold 20,000 shares at an average $73.93 ($1,478,522)

Page 14 of 26 · 502 filings